The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Increasing access to biomarker-driven treatment for lung cancer in Alabama: The Alabama Access initiative.
 
Beth Dickson-Gavney
Consulting or Advisory Role - Amgen (Inst)
Research Funding - Amgen (Inst)
 
Mahir Modi
No Relationships to Disclose
 
Abhinav Vyas
No Relationships to Disclose
 
Ahmed Ismail
No Relationships to Disclose
 
Upal Kunal Basu Roy
Honoraria - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Lilly; Lumanity (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); G1 Therapeutics (Inst); Genentech (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Lilly
 
Ellen McNeeley
No Relationships to Disclose
 
Shuko Harada
No Relationships to Disclose
 
Craig Mackinnon
No Relationships to Disclose
 
Ann Ann Fish-Steagall
Stock and Other Ownership Interests - Amgen
 
Meriam Driss
No Relationships to Disclose
 
Yanis Boumber
Consulting or Advisory Role - G1 Therapeutics; Jazz Pharmaceuticals
Speakers' Bureau - Sanofi/Regeneron
Other Relationship - Alphageneron
 
Maya Khalil
Research Funding - Abbvie (Inst); Advenchen Laboratories (Inst); Amgen (Inst); Arcus Biosciences (Inst); Artios (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb Company (Inst); Cantargia AB (Inst); Caris Life Sciences (Inst); DynamiCure Biotechnology (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Henlius (Inst); Henlius (Inst); Janssen (Inst); Johnson & Johnson/Janssen (Inst); Kronos (Inst); Lilly (Inst); Loxo/Lilly (Inst); Lucence (Inst); Merck (Inst); National Cancer Institute (Inst); NGM Biopharmaceuticals (Inst); Nitto BioPharma (Inst); Numab (Inst); Orum Therapeutics (Inst); Relay Therapeutics (Inst); Seagen (Inst); Spectrum Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TopAlliance BioSciences Inc (Inst); Xencor (Inst); Xencor (Inst)
 
Aakash Desai
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Bristol Myers Squibb; Daichii Sankyo; Foundation Medicine; Janssen Oncology; Merus; Regeneron; Sanofi
Speakers' Bureau - AstraZeneca; Merck